<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 23.6: Pharmacology and Breastfeeding: Risk-Benefit Analysis | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* STAT HIGHLIGHT */
.stat-highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 700;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box p {
 margin: 0;
 font-size: 15px;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: linear-gradient(135deg, #faf5ff, #f3e8ff);
 border: 1px solid #e9d5ff;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.question-item {
 background: white;
 padding: 24px;
 border-radius: 12px;
 margin-bottom: 16px;
 border: 1px solid #e9d5ff;
}

.question-item:last-child {
 margin-bottom: 0;
}

.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}

.question-number {
 background: #a855f7;
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}

.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}

.reveal-btn {
 background: white;
 border: 2px solid #d8b4fe;
 color: #7e22ce;
 padding: 10px 20px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 cursor: pointer;
 transition: all 0.2s;
 margin-top: 12px;
}

.reveal-btn:hover {
 background: #7e22ce;
 color: white;
 border-color: #7e22ce;
}

.answer-text {
 display: none;
 margin-top: 16px;
 padding-top: 16px;
 border-top: 1px solid #e9d5ff;
 color: #4b5563;
 font-size: 15px;
 line-height: 1.6;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.takeaways-box .box-label {
 color: #166534;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}

.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #166534;
 border-bottom: 1px solid rgba(34, 197, 94, 0.2);
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #22c55e;
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}
/* Data Table CSS - MANDATORY for tables */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}
.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}
.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}
.data-table tr:nth-child(even) {
 background: #f9fafb;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 23: L2: Advanced Techniques</span>
 <h1 class="lesson-title">Pharmacology and Breastfeeding: Risk-Benefit Analysis</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 12 min read</span>
 <span class="meta-badge"><span class="icon">üí°</span> Lesson 6 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute</div>
 <div class="title">Certified Breastfeeding Support Coach‚Ñ¢</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#medication-transfer"><span class="section-num">01</span>Medication Transfer to Breast Milk</a></li>
 <li><a href="#hales-categories"><span class="section-num">02</span>Hale‚Äôs Lactation Risk Categories</a></li>
 <li><a href="#galactagogues"><span class="section-num">03</span>Galactagogues: Use & Considerations</a></li>
 <li><a href="#chronic-conditions"><span class="section-num">04</span>Managing Chronic Conditions</a></li>
 <li><a href="#substance-use"><span class="section-num">05</span>Substance Use and Breastfeeding</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In our journey through advanced techniques, we've explored complex anatomies, nipple trauma, induced lactation, and infant barriers. This lesson pivots to a crucial, often anxiety-inducing area: <span class="highlight">the intersection of maternal medication and breastfeeding</span>. Understanding pharmacology is essential for providing comprehensive, evidence-based support and empowering mothers to make informed choices for their health and their baby's wellbeing. It directly impacts our ability to <span class="highlight">Listen & Learn</span> and <span class="highlight">Troubleshoot & Target</span> within the L.A.T.C.H. Support Method‚Ñ¢.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Confident Coach!</h3>
 <p>As a Certified Breastfeeding Support Coach, you'll encounter clients who need to take medication for various reasons ‚Äì from acute infections to chronic health conditions, or even to support milk supply. The thought of medication and breastfeeding can be daunting for new mothers, often leading to unnecessary cessation of breastfeeding due to misinformation or fear. Your role is not to prescribe or advise on specific medications, but to <span class="highlight">empower mothers with accurate, evidence-based information</span> to facilitate informed discussions with their healthcare providers.</p>
 <p>In this lesson, we'll demystify the principles of medication transfer to breast milk, explore trusted resources like Hale's Lactation Risk Categories, and discuss common pharmacological agents, including galactagogues and medications for chronic conditions. You'll gain the confidence to guide clients through these complex decisions, ensuring they feel supported and understood.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Explain the key pharmacokinetic principles governing medication transfer into breast milk.</li>
 <li>Utilize Hale‚Äôs Lactation Risk Categories (L1-L5) to assess potential medication risks during breastfeeding.</li>
 <li>Evaluate the clinical indications, efficacy, and potential side effects of common galactagogues.</li>
 <li>Summarize best practices for breastfeeding mothers managing chronic conditions with various medications.</li>
 <li>Provide evidence-based guidance on common substance use (caffeine, nicotine, alcohol) in the context of breastfeeding.</li>
 <li>Empower clients to collaborate effectively with their healthcare providers regarding medication decisions.</li>
 </ul>
 </div>

 <!-- Opening Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Opening Case Study: Navigating Postpartum Depression Medication</p>
 <p class="subtitle">Sarah's Dilemma</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Client:</strong> Sarah, 38-year-old first-time mother</p>
 <p><strong>Presenting Situation:</strong> 8 weeks postpartum, struggling with severe anxiety, persistent sadness, and difficulty sleeping. Diagnosed with Postpartum Depression (PPD) by her OB-GYN, who recommended Zoloft (Sertraline).</p>
 <p><strong>Breastfeeding Status:</strong> Exclusively breastfeeding her daughter, Lily, who is thriving. Sarah is deeply committed to breastfeeding but terrified of any medication harming her baby.</p>
 </div>
 <p>Sarah reaches out to you, her Certified Breastfeeding Support Coach, overwhelmed with conflicting information from online forums and well-meaning friends. She wants to know if taking Zoloft means she has to stop breastfeeding, and how to assess the risk to Lily.</p>
 <p class="case-context">Sarah's situation is incredibly common. Many mothers face the challenging decision of balancing their own mental and physical health needs with their desire to breastfeed. As a coach, you won't tell her what to do, but you'll equip her with the knowledge to discuss options confidently with her doctor. We will revisit Sarah's journey later in this lesson.</p>
 </div>
 </div>

 <h2 id="medication-transfer">The Science of Medication Transfer to Breast Milk</h2>
 <p>Understanding how medications transfer into breast milk is the foundation of informed decision-making. It's a complex pharmacokinetic process influenced by several factors:</p>

 <h3>Key Pharmacokinetic Principles</h3>
 <ul>
 <li><strong>Maternal Plasma Concentration:</strong> Generally, the higher the drug concentration in the mother's blood, the more likely it is to transfer into milk.</li>
 <li><strong>Molecular Weight:</strong> Smaller molecules (<span class="stat-highlight">&lt;500 Daltons</span>) typically transfer more readily into breast milk. Larger molecules (like insulin or heparin) often have minimal transfer.</li>
 <li><strong>Lipid Solubility:</strong> Highly lipid-soluble (fat-soluble) drugs tend to concentrate in breast milk, which has a higher fat content than plasma.</li>
 <li><strong>Protein Binding:</strong> Drugs that are highly bound to maternal plasma proteins are less available to transfer into milk. Only the "free" (unbound) drug can cross into milk.</li>
 <li><strong>Ionization and pH:</strong> Milk is slightly more acidic (pH 7.0-7.2) than maternal plasma (pH 7.4). Weakly basic drugs tend to become "ion-trapped" in milk, leading to higher concentrations. Weakly acidic drugs are less likely to transfer.</li>
 <li><strong>Milk-to-Plasma (M/P) Ratio:</strong> This ratio compares the drug concentration in milk to its concentration in maternal plasma. An M/P ratio of <span class="stat-highlight">&lt;1.0</span> suggests relatively low transfer, while a ratio <span class="stat-highlight">&gt;1.0</span> indicates higher concentration in milk.</li>
 <li><strong>Bioavailability in Infant:</strong> Even if a drug transfers to milk, how much is absorbed by the infant's gut and how it's metabolized also impacts potential effects. Many drugs are poorly absorbed orally by infants or rapidly metabolized.</li>
 <li><strong>Infant Age and Health:</strong> Preterm or neonates have immature liver and kidney function, making them more susceptible to drug effects. Older infants who consume less milk or are on solids may have lower exposure.</li>
 </ul>
 <p>These factors are evaluated by pharmacologists and lactation experts to determine the risk level of a drug during lactation. It's not just about presence, but about <span class="highlight">clinically significant exposure</span> and potential effect on the infant.</p>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip: Empowering Conversations</div>
 <p>When discussing medication with clients, frame it as an opportunity for proactive health management. Say: "Your commitment to breastfeeding is amazing, and your health matters too. Let's gather the facts so you can have a powerful conversation with your doctor, not just a worried one. We'll focus on understanding the evidence, not making medical decisions." This empowers them to advocate for themselves.</p>
 </div>

 <h2 id="hales-categories">Navigating Medication Safety: Hale‚Äôs Lactation Risk Categories</h2>
 <p>One of the most widely respected resources for medication and lactation information is Dr. Thomas Hale's <span class="highlight">"Medications & Mothers' Milk"</span>. Hale developed a comprehensive risk classification system (L1-L5) that provides a quick reference for healthcare providers and lactation professionals.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Category</th>
 <th>Description</th>
 <th>Interpretation</th>
 <th>Examples (Common)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>L1: Safest</strong></td>
 <td>Drug has been taken by a large number of breastfeeding mothers without any observed increase in adverse effects in the infant. Controlled studies in breastfeeding women have failed to demonstrate a risk to the infant.</td>
 <td>Highly recommended for breastfeeding mothers.</td>
 <td>Ibuprofen, Acetaminophen, Sertraline (Zoloft), Insulin, Amoxicillin</td>
 </tr>
 <tr>
 <td><strong>L2: Safer</strong></td>
 <td>Drug has been studied in a limited number of breastfeeding women without an increase in adverse effects. Risk of adverse effects is remote.</td>
 <td>Generally compatible with breastfeeding; monitor infant for subtle effects.</td>
 <td>Citalopram (Celexa), Fluoxetine (Prozac), Prednisone, Loratadine (Claritin), Penicillin</td>
 </tr>
 <tr>
 <td><strong>L3: Moderately Safe</strong></td>
 <td>No controlled studies in breastfeeding women or only limited controlled studies are available. Risk of adverse effects is possible. Drug may be given if the benefits justify the potential risk.</td>
 <td>Use with caution; consider alternatives or monitor infant closely. Often used when no L1/L2 alternative exists.</td>
 <td>Pseudoephedrine, Metronidazole, Codeine, Hydrocodone, Sumatriptan</td>
 </tr>
 <tr>
 <td><td><strong>L4: Possibly Hazardous</strong></td>
 <td>Positive evidence of risk to a breastfed infant or to milk production, but the benefits of use in breastfeeding mothers may be acceptable despite the risk.</td>
 <td>Avoid if possible; significant risk to infant or milk supply. Consider risks vs. benefits carefully.</td>
 <td>Lithium, Amiodarone, Ergotamine, Chloramphenicol</td>
 </tr>
 <tr>
 <td><strong>L5: Contraindicated</strong></td>
 <td>Significant and demonstrated risk to the infant from breastfeeding or to milk production. Risks clearly outweigh any possible benefit.</td>
 <td>Absolutely contraindicated. Breastfeeding should be discontinued.</td>
 <td>Chemotherapy agents, Radioactive iodine, Amphetamines, Recreational drugs of abuse</td>
 </tr>
 </tbody>
 </table>
 <p>It's important to remember that these categories are a guide. Individual circumstances, infant age, dosage, and duration of treatment all play a role. Always refer to the most current edition of Hale's or other authoritative databases like LactMed for the most up-to-date information.</p>

 <div class="alert-box info">
 <p class="alert-label">Important Note for Coaches</p>
 <p>Your role is to educate and inform, not to diagnose or recommend specific medications. Always advise clients to consult their prescribing physician or a lactation-specific pharmacologist. Provide resources like LactMed (a free NIH database) or direct them to their local IBCLC for medication discussions. This ensures you stay within your scope of practice.</p>
 </div>

 <h2 id="galactagogues">Galactagogues: When and How to Use Them</h2>
 <p>Galactagogues are medications or herbs used to increase milk supply. They work by increasing prolactin levels, the hormone responsible for milk production. While not a first-line solution, they can be valuable in specific situations, particularly when non-pharmacological interventions (e.g., increased frequency/effectiveness of milk removal, improved latch, stress reduction) have been optimized.</p>

 <h3>Domperidone: Mechanism, Efficacy, and Risks</h3>
 <p>Domperidone is a dopamine antagonist that increases prolactin secretion. It is widely used off-label as a galactagogue in many countries (e.g., Canada, Australia, Europe) but is <span class="highlight">not FDA-approved in the United States</span> for this purpose due to potential cardiac risks, particularly when administered intravenously or in high doses to vulnerable populations.</p>
 <ul>
 <li><strong>Mechanism:</strong> Blocks dopamine receptors, leading to an increase in prolactin. It has minimal ability to cross the blood-brain barrier, reducing central nervous system side effects compared to Metoclopramide.</li>
 <li><strong>Efficacy:</strong> Studies show it can increase milk supply, particularly in mothers with true low supply or those inducing lactation. A meta-analysis of <span class="stat-highlight">18 studies (n=1,440)</span> found domperidone significantly increased milk volume compared to placebo (Grzeskowiak et al., 2018).</li>
 <li><strong>Side Effects (Maternal):</strong> Headache, abdominal cramping, dry mouth. More serious, but rare, side effects include QT prolongation and cardiac arrhythmias, especially in individuals with pre-existing cardiac conditions or electrolyte imbalances.</li>
 <li><strong>Infant Exposure:</strong> Very low transfer into breast milk (Hale's L1). No significant adverse effects have been reported in breastfed infants.</li>
 </ul>

 <h3>Metoclopramide (Reglan): Mechanism, Efficacy, and Risks</h3>
 <p>Metoclopramide is another dopamine antagonist, FDA-approved for gastrointestinal issues, and also used off-label as a galactagogue in the US.</p>
 <ul>
 <li><strong>Mechanism:</strong> Similar to domperidone, it blocks dopamine receptors, increasing prolactin. However, it crosses the blood-brain barrier more readily.</li>
 <li><strong>Efficacy:</strong> Can increase milk supply, but its efficacy is often debated in comparison to domperidone. Response rates vary.</li>
 <li><strong>Side Effects (Maternal):</strong> Due to its ability to cross the blood-brain barrier, it has a higher incidence of central nervous system side effects, including fatigue, irritability, depression, and extrapyramidal symptoms (e.g., tremors, restlessness). The risk of depression is a significant concern for mothers with a history of mood disorders.</li>
 <li><strong>Infant Exposure:</strong> Low transfer into breast milk (Hale's L2). While generally considered safe for the infant, close monitoring is advised due to the potential for maternal side effects impacting care.</li>
 </ul>
 <p><strong>Counseling Considerations:</strong> For clients considering galactagogues, emphasize that these are not magic pills. They should always be used under medical supervision, after thorough assessment of the root cause of low supply, and only after non-pharmacological strategies have been exhausted. Your role in the <span class="highlight">Assess & Align</span> and <span class="highlight">Troubleshoot & Target</span> phases of L.A.T.C.H. is crucial here, ensuring foundational breastfeeding practices are optimized first.</p>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip: Holistic Approach to Supply</div>
 <p>Remind clients that true low supply is rare, affecting <span class="stat-highlight">less than 5%</span> of mothers. The vast majority of perceived low supply issues can be resolved through optimizing milk removal, frequency, latch, and maternal self-care (sleep, nutrition, stress reduction). Galactagogues are a last resort, not a first step. Encourage your clients to prioritize the holistic habits from Module 5, like <span class="highlight">Nutrient-Dense Nutrition</span> and <span class="highlight">Stress Management</span>, before considering medication.</p>
 </div>

 <h2 id="chronic-conditions">Managing Chronic Conditions While Breastfeeding</h2>
 <p>Many women manage chronic conditions (e.g., depression, hypertension, diabetes, autoimmune diseases) that require ongoing medication. The goal is always to find the safest and most effective treatment plan that supports both maternal and infant health, ideally allowing continued breastfeeding.</p>

 <h3>Antidepressants: SSRIs and SNRIs</h3>
 <p>Postpartum depression and anxiety are common, affecting up to <span class="stat-highlight">1 in 7 women</span>. Many effective antidepressants are compatible with breastfeeding.</p>
 <ul>
 <li><strong>Sertraline (Zoloft):</strong> Considered one of the safest antidepressants during lactation (Hale's L1). It has minimal transfer into breast milk, and infant serum levels are often undetectable.</li>
 <li><strong>Paroxetine (Paxil) and Citalopram (Celexa):</strong> Also generally considered compatible (Hale's L2).</li>
 <li><strong>Fluoxetine (Prozac):</strong> Has a longer half-life and higher infant serum levels, making it less preferred as a first-line choice, but still often used (Hale's L2).</li>
 <li><strong>Risk-Benefit:</strong> Untreated maternal depression poses significant risks to both mother and infant (e.g., impaired bonding, developmental delays). The benefits of treating maternal depression often far outweigh the minimal risks associated with compatible antidepressants.</li>
 </ul>

 <h3>Analgesics: Pain Management</h3>
 <p>Pain management is crucial, especially postpartum. Many common pain relievers are safe.</p>
 <ul>
 <li><strong>Acetaminophen (Tylenol) and Ibuprofen (Advil, Motrin):</strong> Both are widely considered safe (Hale's L1). They transfer into breast milk in very small, clinically insignificant amounts.</li>
 <li><strong>Naproxen (Aleve):</strong> Also a good option, generally compatible (Hale's L2).</li>
 <li><strong>Opioids (Codeine, Hydrocodone, Oxycodone):</strong> Use with caution. Codeine can be problematic due to genetic variations in metabolism (ultrarapid metabolizers) leading to high opioid levels in milk. All opioids can cause infant sedation and respiratory depression, especially in neonates. Use lowest effective dose for shortest duration, and monitor infant closely for sedation, poor feeding, and respiratory issues (Hale's L3-L4).</li>
 </ul>

 <h3>Antibiotics: Common Prescriptions</h3>
 <p>Bacterial infections are common, especially mastitis. Many antibiotics are safe for breastfeeding.</p>
 <ul>
 <li><strong>Penicillins (Amoxicillin, Dicloxacillin) and Cephalosporins (Cephalexin):</strong> Generally considered safe and compatible (Hale's L1-L2). Minor infant side effects like mild diarrhea or rash are possible but rare.</li>
 <li><strong>Macrolides (Azithromycin, Erythromycin):</strong> Also typically compatible (Hale's L2).</li>
 <li><strong>Tetracyclines (Doxycycline):</strong> Short-term use of most tetracyclines is considered compatible (Hale's L2) as calcium in milk binds the drug, limiting infant absorption. Long-term use or use in neonates should be evaluated carefully.</li>
 <li><strong>Fluoroquinolones (Ciprofloxacin):</strong> Generally considered compatible (Hale's L3), but some concerns exist regarding potential cartilage effects in infants, though evidence is limited.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">‚úÖ</div>
 <div>
 <p class="title">Revisiting Sarah: Empowered Decisions</p>
 <p class="subtitle">Finding Her Path with PPD Medication</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Client:</strong> Sarah, 38-year-old first-time mother</p>
 <p><strong>Intervention:</strong> After your coaching session, Sarah felt empowered. You provided her with resources on Sertraline's safety profile during lactation (Hale's L1, low transfer) and explained the concept of risk-benefit analysis, emphasizing that untreated PPD could impact her ability to care for Lily and enjoy motherhood. You also discussed how to monitor Lily for any subtle changes (sleepiness, fussiness, feeding issues), although unlikely.</p>
 <p><strong>Outcome:</strong> Sarah spoke with her OB-GYN, feeling prepared and confident. She started on a low dose of Sertraline. Within 4 weeks, her anxiety significantly reduced, and her mood improved. She continued to exclusively breastfeed Lily, who showed no adverse effects. Sarah reported feeling more connected to Lily and herself, and relieved that she didn't have to choose between her mental health and breastfeeding.</p>
 </div>
 <p class="case-context">This case highlights the profound impact a knowledgeable Breastfeeding Support Coach can have. By providing accurate information and fostering confidence, you enable mothers to make choices that support their entire family's well-being, aligning with the <span class="highlight">Comfort & Connection</span> aspect of the L.A.T.C.H. method.</p>
 </div>
 </div>

 <h2 id="substance-use">Substance Use and Breastfeeding: Practical Guidance</h2>
 <p>Clients may ask about the safety of social substances. Your guidance should be evidence-based and non-judgmental, focusing on harm reduction and informed choices.</p>

 <h3>Caffeine</h3>
 <ul>
 <li><strong>Transfer:</strong> Caffeine transfers into breast milk (M/P ratio <span class="stat-highlight">~0.5-1.0</span>).</li>
 <li><strong>Impact:</strong> Most infants tolerate moderate maternal caffeine intake well. High intake (<span class="stat-highlight">&gt;500 mg/day</span>, equivalent to 5+ cups of coffee) can cause irritability, jitteriness, and sleep disturbances in sensitive infants, especially newborns.</li>
 <li><strong>Guidance:</strong> Moderate intake (up to <span class="stat-highlight">300 mg/day</span>, 2-3 cups of coffee) is generally considered safe. Advise mothers to observe their infant for any signs of sensitivity.</li>
 </ul>

 <h3>Nicotine</h3>
 <ul>
 <li><strong>Transfer:</strong> Nicotine readily transfers into breast milk, with levels in milk often <span class="stat-highlight">2.9 times higher</span> than maternal plasma (Dahlstrom et al., 2008).</li>
 <li><strong>Impact:</strong> Nicotine exposure through breast milk can lead to infant fussiness, sleep disturbances, vomiting, and even nicotine toxicity in high doses. Smoking also reduces milk supply and exposes the infant to secondhand smoke.</li>
 <li><strong>Guidance:</strong> While breastfeeding is still recommended for smokers (due to the protective benefits outweighing risks of *not* breastfeeding), mothers should be strongly encouraged to quit. If quitting is not possible, reduce exposure by smoking immediately after a feeding, away from the infant, and never indoors.</li>
 </ul>

 <h3>Alcohol</h3>
 <ul>
 <li><strong>Transfer:</strong> Alcohol transfers into breast milk and peaks in milk at roughly the same time it peaks in the mother's blood (typically <span class="stat-highlight">30-60 minutes</span> after consumption, or longer with food).</li>
 <li><strong>Impact:</strong> Alcohol can inhibit the milk ejection reflex, temporarily decrease milk production, and affect infant sleep patterns and motor development with chronic exposure.</li>
 <li><strong>Guidance:</strong> Moderate alcohol consumption (1 standard drink) is generally considered acceptable. The "pump and dump" method is largely unnecessary as alcohol leaves the milk as it leaves the bloodstream. Advise mothers to wait at least <span class="stat-highlight">2 hours per standard drink</span> before breastfeeding (e.g., if consuming 1 drink, wait 2 hours; if 2 drinks, wait 4 hours). Test strips for alcohol in milk exist but have limited accuracy and are not generally recommended over timing.</li>
 </ul>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip: Non-Judgmental Support</div>
 <p>When discussing sensitive topics like substance use, maintain a compassionate, non-judgmental stance. Your goal is to provide accurate information and support harm reduction, not to shame. Start by acknowledging the mother's desire to do what's best for her baby, then offer practical, evidence-based strategies. For instance, "Many moms enjoy a glass of wine, and with a little planning, you can still breastfeed safely."</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">1</span>
 <p class="question-text">Which pharmacokinetic principle primarily explains why large molecules like insulin have minimal transfer into breast milk?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p>The primary principle is <strong>Molecular Weight</strong>. Drugs with a molecular weight of less than 500 Daltons typically transfer more readily into breast milk. Insulin, being a much larger protein molecule, has difficulty crossing into milk.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">2</span>
 <p class="question-text">A client is prescribed an antibiotic for mastitis. She asks if she needs to stop breastfeeding. Using Hale's Lactation Risk Categories, which category would most common antibiotics like Amoxicillin or Cephalexin fall under, and what does this imply?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p>Most common antibiotics like Amoxicillin or Cephalexin fall under <strong>Hale's L1 (Safest) or L2 (Safer)</strong>. This implies they are generally compatible with breastfeeding, with a very low or remote risk of adverse effects to the infant. The benefits of treating the maternal infection and continuing breastfeeding usually outweigh any minimal risks.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">3</span>
 <p class="question-text">A mother considering Domperidone to increase her milk supply asks you about its regulatory status in the U.S. What should you tell her?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p>You should inform her that Domperidone is <strong>not FDA-approved in the United States</strong> for use as a galactagogue due to concerns about potential cardiac side effects. It is available in many other countries, but in the U.S., its use for lactation is considered off-label and often requires special compounding or specific medical circumstances, always under strict medical supervision.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">4</span>
 <p class="question-text">A client who occasionally enjoys a glass of wine asks about the "pump and dump" method. What is the evidence-based guidance you would share regarding alcohol and breastfeeding?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p>You would explain that the "pump and dump" method is generally unnecessary for occasional alcohol consumption. Alcohol leaves breast milk as it leaves the bloodstream. The evidence-based guidance is to <strong>wait at least 2 hours per standard alcoholic drink</strong> before breastfeeding. This allows the alcohol to metabolize out of the milk. Monitoring the infant for any unusual sleepiness or changes in feeding is also advised, especially with higher consumption.</p>
 </div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Medication transfer to breast milk is a complex process influenced by molecular weight, lipid solubility, protein binding, and the M/P ratio.</li>
 <li>Hale's Lactation Risk Categories (L1-L5) provide a valuable framework for assessing medication safety during breastfeeding, guiding conversations with healthcare providers.</li>
 <li>Galactagogues like Domperidone and Metoclopramide can increase milk supply but have specific indications, efficacy profiles, and potential side effects, requiring careful medical supervision.</li>
 <li>Many common medications for chronic conditions (e.g., certain antidepressants, analgesics, antibiotics) are compatible with breastfeeding, making informed risk-benefit analysis crucial.</li>
 <li>For substances like caffeine, nicotine, and alcohol, evidence-based guidance focuses on moderation and timing to minimize infant exposure while supporting maternal wellbeing.</li>
 <li>As a Breastfeeding Support Coach, your role is to empower mothers with accurate information and resources to facilitate informed decision-making with their healthcare team, always staying within your scope of practice.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Anderson, P. O., & Sauberan, J. B. (2016). Modeling drug distribution in human milk. <em>Journal of Human Lactation, 32</em>(3), 434-443.</li>
 <li>Dahlstrom, A., et al. (2008). Cotinine in breast milk and maternal smoking. <em>Acta Paediatrica, 97</em>(12), 1673-1678.</li>
 <li>Grzeskowiak, L. E., et al. (2018). The effect of domperidone on milk production in women with insufficient lactation: A systematic review and meta-analysis. <em>Journal of Human Lactation, 34</em>(2), 246-253.</li>
 <li>Hale, T. W., & Rowe, H. E. (2023). <em>Medications & Mothers' Milk: A Manual of Lactational Pharmacology (20th ed.)</em>. Springer Publishing Company.</li>
 <li>LactMed. (Updated regularly). <em>Drugs and Lactation Database (LactMed)</em>. National Library of Medicine (US). Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK507889/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK507889/</a></li>
 <li>Orsolini, L., et al. (2020). Pharmacological and non-pharmacological treatment of postpartum depression: A systematic review. <em>Journal of Clinical Psychopharmacology, 40</em>(3), 282-297.</li>
 <li>Schrager, S. (2018). Alcohol and breastfeeding. <em>American Family Physician, 97</em>(8), 514-518.</li>
 <li>Uguz, F. (2019). Selective serotonin reuptake inhibitors and breastfeeding: A systematic review of the literature. <em>Breastfeeding Medicine, 14</em>(2), 77-84.</li>
 </ol>
 </div>

</div>

<script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>